Hofseth BioCare ASA (LON:0Q6H)
1.950
0.00 (0.00%)
At close: Apr 30, 2025
Hofseth BioCare ASA Revenue
In the year 2024, Hofseth BioCare ASA had annual revenue of 265.54M NOK with 21.52% growth. Hofseth BioCare ASA had revenue of 64.89M in the quarter ending December 31, 2024, with 36.82% growth.
Revenue
265.54M NOK
Revenue Growth
+21.52%
P/S Ratio
3.10
Revenue / Employee
3.74M NOK
Employees
71
Market Cap
57.85M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 265.54M | 47.03M | 21.52% |
Dec 31, 2023 | 218.51M | 98.06M | 81.42% |
Dec 31, 2022 | 120.45M | 32.83M | 37.47% |
Dec 31, 2021 | 87.62M | 18.36M | 26.52% |
Dec 31, 2020 | 69.25M | 1.47M | 2.17% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
Shell | 227.10B |
HSBC Holdings | 44.89B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |